Obesity drug developer Aardvark Therapeutics (AARD) has filed for a $100M initial public offering. Aardvark (AARD) didn't ...

Companies may be going whale-hunting as the Trump administration aspires to loosen up regulations. "I think the regulatory ...

In a report released today, Gavin Parsons from UBS maintained a Hold rating on Boeing (BA – Research Report), with a price target of $208.00.

Ladies and gentlemen, thank you for standing by. My name is Abby and I'll be your conference operator today. (Operator Instructions) Thank you. And I would now like to turn the conference over to ...

RBC Capital analyst Gordon Ramsay CFA maintained a Hold rating on Ampol Limited (CTXAF – Research Report) on January 22 and set a price target ...

Morgan Stanley is exploring the possibility of offering crypto to clients and is currently discussing a “safe” way to expand its services with regulators.

Francois Cedric, the Chief Executive Officer of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a $3.86 billion market cap ...

Pascal Deschatelets, the Chief Scientific Officer of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a biopharmaceutical company with a market capitalization of $3.9 billion and currently trading near ...